ClinicalTrials.gov
public full text
Public Domain
Intravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine Treatment
The purpose of this clinical trial is to determine if the investigational drug is able to reduce/shrink advanced breast cancer tumors in patients who no longer benefit from anthracyclines, taxanes and capecitabine.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Gemcitabine Monotherapy for Metastatic Breast Cancer After Anthracycline and Taxane Regimen#994263
- ModraDoc006/r in Patients With Breast Cancer#826283
- Sodium-glucose Transporter Type 2 Inhibition in Anthracycline-related Cardiotoxicity#1030904
- Capecitabine in Women With Operable Breast Cancer#1057153
- Utidelone Capsule Plus Capecitabine (CAP) for Metastatic Breast Cancer#1139099
Record · ID 829043
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive